Prostate cancer advances help extend a patient's life

September 11, 2018 | Dory Benford

Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.

Continue Reading

Promising Sickle Cell Research Gets Nearly $6MM Boost from CIRM

March 22, 2018 | Michael Easterling

Thanks to a $5.74 million award from the California Institute for Regenerative Medicine, City of Hope’s Joseph Rosenthal, M.D., and his team can advance their research into finding a cure for sickle cell disease.

New Clues Could Point to Better Treatments for Chronic Graft-Versus-Host Disease (GVHD)

November 9, 2017 | By Katie Neith

City of Hope’s Defu Zeng, professor of diabetes immunology and hematopoietic cell transplantation and colleagues recently uncovered important information about the chronic GVHD.

Novel Treatment May Stop Graft-Versus-Host Disease

April 18, 2017 | Katie Neith

An international team of researchers led by City of Hope’s Defu Zeng believe they may have found a way to prevent graft-versus host disease following stem cell transplants without sacrificing the transplants’ ability to fight leukemia and lymphoma.

Type 1 Diabetes: A Primer

January 24, 2017 | Samantha Bonar

Type 1 diabetes is an autoimmune disorder in which the body’s immune system attacks and destroys the insulin-producing beta cells of the pancreas. Here's a look at the past, present and future of this disease.

$2.2 million grant will benefit graft-versus-host disease research

November 20, 2015 | City of Hope

Graft-versus-host disease is a serious condition that affects many people who receive a bone marrow cell transplant. To better fight it, scientists need to better understand it. City of Hope researchers’ efforts to do just that recently got a $2.2 million boost from the National Institute of Allergy and Infectious Diseases, also known as NIAID.

Diabetes research: From epigenetics to islet cell transplants

January 4, 2014 | Elizabeth Stewart

Nearly 350 million people worldwide are coping with diabetes, and the disease is expected to be the seventh-leading cause of death by 2030. Aware of these grim statistics, researchers at City of Hope are committed to halting the global epidemic.

She lost brother to graft-versus-host disease; now she fights back

August 9, 2013 | Nicole White

Rosie Mae Henson is continuing a fight she feels her brother John should have won. John successfully conquered his cancer with a bone marrow transplant, but died a year later from graft-versus-host disease in which the new donor cells attack the transplant recipient’s body.